Literature DB >> 11698149

In depth pharmacological characterization of endothelin B receptors in the rat middle cerebral artery.

D Szok1, J Hansen-Schwartz, L Edvinsson.   

Abstract

Whereas the endothelin A receptor is generally believed to mediate vasoconstriction; the endothelin B receptor seems elusive; both dilative and constrictive responses have been reported. Using the in vitro arteriograph, a method allowing compartmentalized study of vessel segments, segments of rat middle cerebral artery were cannulated with micropipettes, pressurized and luminally perfused. Vessel diameters were evaluated using a microscope equipped with an imaging system. Both intra- and extraluminal applications of endothelin-1 produced constriction. Intraluminal administration of a selective endothelin B receptor agonist sarafotoxin 6c in precontracted cerebral arteries and in the presence of the endothelin A receptor blocker FR139317 caused vasodilation in a concentration-dependent manner. Inhibition of nitric oxide synthase significantly reduced the dilation induced by sarafotoxin 6c, whereas inhibition of cyclooxygenase and endothelium-derived hyperpolarizing factor did not.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698149     DOI: 10.1016/s0304-3940(01)02293-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Vascular plasticity in cerebrovascular disorders.

Authors:  Lars I H Edvinsson; Gro Klitgaard Povlsen
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-11       Impact factor: 6.200

2.  Alterations in nitric oxide and endothelin-1 bioactivity underlie cerebrovascular dysfunction in ApoE-deficient mice.

Authors:  Kazuo Yamashiro; Alexandra B Milsom; Johan Duchene; Catherine Panayiotou; Takao Urabe; Nobutaka Hattori; Amrita Ahluwalia
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-17       Impact factor: 6.200

Review 3.  Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease.

Authors:  Marc Q Mazzuca; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2012-03-30       Impact factor: 5.858

4.  MEK1/2 inhibition attenuates vascular ETA and ETB receptor alterations after cerebral ischaemia.

Authors:  Marie Henriksson; Emelie Stenman; Petter Vikman; Lars Edvinsson
Journal:  Exp Brain Res       Date:  2006-11-08       Impact factor: 1.972

5.  Endothelin B receptor dysfunction mediates elevated myogenic tone in cerebral arteries from aged male Fischer 344 rats.

Authors:  Alexander P Young; Jiequan Zhu; Amina M Bagher; Eileen M Denovan-Wright; Susan E Howlett; Melanie E M Kelly
Journal:  Geroscience       Date:  2021-01-05       Impact factor: 7.713

6.  Neural differentiation of transplanted neural stem cells in a rat model of striatal lacunar infarction: light and electron microscopic observations.

Authors:  Vilma C Muñetón-Gómez; Ernesto Doncel-Pérez; Ana P Fernandez; Julia Serrano; Andrea Pozo-Rodrigálvarez; Lara Vellosillo-Huerta; Julian S Taylor; Gloria P Cardona-Gómez; Manuel Nieto-Sampedro; Ricardo Martínez-Murillo
Journal:  Front Cell Neurosci       Date:  2012-08-02       Impact factor: 5.505

7.  Secondhand smoke exposure induces Raf/ERK/MAPK-mediated upregulation of cerebrovascular endothelin ETA receptors.

Authors:  Lei Cao; Cang-Bao Xu; Yaping Zhang; Yong-Xiao Cao; Lars Edvinsson
Journal:  BMC Neurosci       Date:  2011-11-01       Impact factor: 3.288

8.  Enhancement of bradykinin-induced relaxation by focal brain ischemia in the rat middle cerebral artery: Receptor expression upregulation and activation of multiple pathways.

Authors:  Youhai Li; Natalia Lapina; Nina Weinzierl; Lothar Schilling
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

9.  Up-regulation of endothelin type B receptors in the human internal mammary artery in culture is dependent on protein kinase C and mitogen-activated kinase signaling pathways.

Authors:  David Nilsson; Lotta Gustafsson; Angelica Wackenfors; Bodil Gesslein; Lars Edvinsson; Per Paulsson; Richard Ingemansson; Malin Malmsjö
Journal:  BMC Cardiovasc Disord       Date:  2008-09-08       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.